Quince Therapeutics, Inc. (QNCX) — Financial Flexibility Index
Quince Therapeutics, Inc. (QNCX) has a Financial Flexibility Index of -0.09x as of September 2025. Free cash flow of $-9.85 Million (operating CF $-9.93 Million minus capex $74.00K) represents 0% of total liabilities ($108.84 Million). Also explore QNCX net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Quince Therapeutics, Inc. Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for Quince Therapeutics, Inc. across 8 annual periods. Check QNCX capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Quince Therapeutics, Inc. (2017–2024)
Year-by-year free cash flow to debt coverage for Quince Therapeutics, Inc.. For the full company profile including market capitalisation, see QNCX company net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.38x | $-31.65 Million | $-31.90 Million | $84.33 Million | ▼ -96.9% |
| 2023 | -0.19x | $-18.13 Million | $-18.29 Million | $95.12 Million | ▲ +98.6% |
| 2022 | -13.24x | $-43.91 Million | $-44.04 Million | $3.32 Million | ▼ -208.8% |
| 2021 | -4.29x | $-62.75 Million | $-62.93 Million | $14.64 Million | ▼ -45.2% |
| 2020 | -2.95x | $-50.77 Million | $-50.82 Million | $17.20 Million | ▲ +21.0% |
| 2019 | -3.74x | $-33.22 Million | $-33.28 Million | $8.89 Million | ▲ +52.6% |
| 2018 | -7.88x | $-11.48 Million | $-11.70 Million | $1.46 Million | ▼ -2163.2% |
| 2017 | -0.35x | $-9.75 Million | $-9.83 Million | $28.00 Million | — |